Health-tech startup Asterix Health has successfully secured £2.1 million in a pre-seed funding round to tackle critical workforce shortages in the NHS. The investment, led by Triple Point, will scale the company's innovative platform that connects remote, UK-registered GPs with primary care practices. This new model aims to increase capacity and improve patient access by leveraging a global talent pool.
Addressing a Critical Need in Primary Care
The company was founded in 2024 by Julian Titz and Max Thilo, who were motivated by their personal experiences with serious health conditions. They identified a pressing need for more timely and preventative care, which is often hindered by chronic staffing issues within the NHS. Their mission is to provide a sustainable remedy to the increasing pressure on primary care services.
Asterix Health offers a unique solution by being the first company approved under new regulations to hire GMC-registered doctors based abroad. This approach directly addresses the challenge of a shrinking domestic workforce, where many doctors have considered moving overseas. It effectively grows the available talent pool rather than simply redistributing existing resources within the United Kingdom.
A Technology-Driven Workforce Solution
The core of the service is a proprietary platform called DoctorOS, which facilitates remote support for NHS practices. Remote GPs handle time-consuming tasks such as clinical administration and telephone consultations, freeing up local doctors for in-person appointments. This system is designed to seamlessly integrate into the daily workflow of a busy primary care practice.
To ensure safe and effective care, the DoctorOS platform integrates directly with established Electronic Patient Record Systems, including EMIS and SystmOne. This provides remote clinicians with the complete patient context required to make informed decisions. The focus on secure integration underscores the company's commitment to maintaining high standards of quality and governance.
To date, the platform has enabled the delivery of over 3,000 hours of care, supporting practices that serve a combined 250,000 patients. Early partners report saving the equivalent of one GP session per day, allowing them to reallocate time to proactive patient services. If adopted widely, the model could save the NHS an estimated £250 million annually.
Strategic Funding and Leadership Expansion
The £2.1 million in capital will be instrumental in accelerating the company's growth and impact across the healthcare system. The primary goals are to expedite the onboarding of new NHS practices and significantly expand its network of remote GMC-registered GPs. This strategic expansion will bring its innovative workforce solution to more patients and providers across the country.
Bolstering its clinical leadership, Asterix Health has appointed Dr. Mike Bewick as its Strategic Medical Lead. Dr. Bewick's extensive experience as a former Deputy Medical Director of NHS England for Primary Care adds significant credibility and strategic insight. His appointment signals a strong focus on clinical excellence and a deep understanding of the NHS landscape.
Investors have expressed strong confidence in the company's vision to create a more sustainable primary care workforce. Lead investor Triple Point highlighted the model's ability to unlock a new pool of medical talent to meet growing demand. The round also saw participation from D2, Entrepreneurs First, and Basis Capital, among others.
This pre-seed funding marks a significant milestone for Asterix Health, positioning it to make a tangible impact on UK primary care. By combining technology with a global network of qualified doctors, the company offers a scalable and sustainable solution to long-standing workforce challenges. The investment validates a new approach that promises to enhance efficiency, reduce costs, and improve patient access to essential healthcare services.